| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASML | Technology | New Street Research | Upgrade | Neutral → Buy | — | $602.8B | $437.27 | +0.7% | +5.7% | +2.3% | +2.8% | -0.4% | -2.0% |
| AMAT | Technology | New Street Research | Upgrade | Neutral → Buy | — | $344.9B | $78.66 | +0.2% | +4.8% | +3.1% | +3.0% | +0.7% | -1.8% |
| T | Communication Services | TruistA | Upgrade | Hold → Buy | — | $179.3B | $16.74 | +0.5% | +2.2% | +2.4% | +1.0% | +2.5% | -0.6% |
| MRNA | Healthcare | SVB Leerink | Upgrade | Underperform → Market Perform | — | $17.8B | $118.38 | +4.6% | +8.4% | +3.7% | +2.7% | +4.0% | +1.5% |
| GFL | Industrials | BofA SecuritiesA | Upgrade | Neutral → Buy | — | $14.0B | $25.02 | +1.5% | +4.4% | -0.2% | +2.5% | -1.6% | +0.1% |
| ACI | Consumer Defensive | BMO CapitalC | Upgrade | Underperform → Market Perform | — | $9.3B | $27.50 | -24.9% | -23.3% | -1.4% | -0.4% | -1.3% | -0.3% |
| HQY | Healthcare | Goldman SachsB | Upgrade | Sell → Neutral | — | $7.4B | $73.98 | +1.4% | +2.2% | -0.1% | +0.5% | -0.2% | -2.4% |
| QLYS | Technology | NeedhamA | Upgrade | Hold → Buy | — | $3.6B | $130.57 | +2.5% | +2.1% | +0.4% | +3.9% | +0.0% | +0.9% |
| GOOS | Consumer Cyclical | OTR GlobalC | Upgrade | Negative → Mixed | — | $914M | $17.49 | -0.6% | +2.3% | -4.8% | +5.3% | -2.1% | -4.4% |
| FMAO | Financial Services | Piper SandlerA | Upgrade | Underweight → Neutral | — | $371M | $25.33 | +0.9% | +8.5% | +3.4% | +0.4% | +1.0% | -0.7% |